Before you put a product on the market, you need to be sure that it fulfils its purpose – particularly when the commodities it protects are worth large sums of money and priceless when it comes to human life. To that end, Envirotainer has invested in three new testing chambers to enable rigorous testing of container performance in all kinds of temperatures. It has in effect doubled its testing capacities at its Rosersberg testing facility. Located to the north of Stockholm, the facility is now equipped with six chambers. Four are medium-sized chambers, one is a large chamber capable of maintaining temperatures of between -40°C and +60°C, and the sixth is a small chamber for freezing conditions down to -70°C. These rooms enable tests in a wide range of temperatures and humidity, whilst an accompanying EMC (Electromagnetic Compatibility) chamber allows Envirotainer to verify that its containers continue to meet stringent electromagnetic compatibility standards. “The company can currently certify emissions for its containers below one gigahertz, which speeds up the approval process and benefits customers with faster delivery of compliant solutions. Future plans include investment to enhance testing capabilities up to 6 GHz and potentially assess how radiation affects packaging solutions,” the release explains. Just one of a number of scenarios to make sure that precious pharma cargo is kept intact during its entire journey, reaching the patient in a safe and optimum condition. With the expanded testing facility, Envirotainer can carry out in-house testing, thus bring new, improved products to market more quickly.
Camilla Engbrink, Chief Technology Officer at Envirotainer, said: “These advancements mean our customers can transport their sensitive pharmaceuticals with greater confidence. Our enhanced testing capabilities allow us to simulate extreme conditions, ensuring that our containers perform reliably no matter where they are shipped. This translates to fewer risks and more consistent protection for valuable medical products, ultimately helping to safeguard patient health.”
